Author:
Lopez Laureen M,Grimes David A,Gallo Maria F,Schulz Kenneth F
Reference68 articles.
1. Efficacy, acceptability and tolerability of the combined contraceptive ring, NuvaRing, compared with an oral contraceptive containing 3 µg of ethinyl estradiol and 3 mg of drospirenone;Ahrendt;Contraception,2006
2. Effects on cycle control and bodyweight of the combined contraceptive ring, NuvaRing, versus an oral contraceptive containing 30 µg ethinyl estradiol and 3 mg drospirenone;Milsom;Human Reproduction,2006
3. Evaluation of contraceptive efficacy and cycle control of a transdermal contraceptive patch vs an oral contraceptive: a randomized controlled trial;Audet;Journal of the American Medical Association,2001
4. Comparison of cycle control and side effects between transdermal contraceptive patch and an oral contraceptive in women older than 35 years;Boonyarangkul;Journal of the Medical Association of Thailand,2007
5. Transdermal contraception: evaluation of three transdermal norelgestromin/ethinyl estradiol doses in a randomized, multicenter, dose-response study;Dittrich;American Journal of Obstetrics and Gynecology,2002
Cited by
26 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献